NCT06351332 2026-01-12
ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC
Dana-Farber Cancer Institute
Phase 1/2 Active not recruiting
Dana-Farber Cancer Institute
Lund University Hospital
Jiangsu Hansoh Pharmaceutical Co., Ltd.
National Cancer Institute (NCI)
UNICANCER
Sichuan Provincial People's Hospital